DICE-TB PCR Plus Panel (Qualitative) by Real Time PCR
Test Overview
DICE-TB PCR Plus Panel is a molecular diagnostic test designed to detect Mycobacterium tuberculosis (MTB) DNA and selected tuberculosis-associated resistance markers using Real-Time PCR. It provides rapid molecular detection that can support the evaluation of suspected tuberculosis and guide further clinical management.
Why is this Test Done?
-
Evaluation of suspected tuberculosis (TB)
- Detection of MTB genetic material in the appropriate clinical specimen
- Assessment in patients with symptoms suggestive of TB
- Support in cases of unexplained infection or reproductive-health concerns where TB may be considered
- Helps clinicians make timely decisions regarding further investigations and treatment
Test Method
Real-Time Polymerase Chain Reaction (Real-Time PCR)
The technique detects specific microbial genetic material and can provide molecular results more rapidly than conventional culture-based approaches.
Test Type
Qualitative – reports whether the targeted genetic material is detected or not detected.
Clinical Significance
A positive result indicates detection of the targeted MTB genetic material and should be interpreted along with clinical findings and other investigations. A negative result does not completely exclude TB, particularly when the organism is present at a low level or the specimen is inadequate.
Who May Be Advised This Test?
The test may be considered for individuals with:
- Persistent or unexplained symptoms where TB is suspected
- Clinical findings suggestive of tuberculosis
- Unexplained pelvic or reproductive-health concerns where genital TB is part of the differential diagnosis
- Situations requiring rapid molecular investigation for TB
Important Note
Test interpretation should be performed by a qualified healthcare professional. The exact specimen type, collection requirements, targeted organisms/markers, and resistance markers should be confirmed with the laboratory before testing.
DICE-TB PCR Plus Panel helps provide rapid molecular evidence to support the diagnosis and management of suspected tuberculosis